Abstract
Employers and governments are interested in the use of serological (antibody) testing to allow people to return to work before there is a vaccine for SARS-CoV-2. We articulate the preconditions needed for the implementation of antibody testing, including the role of the U.S. Food & Drug Administration.
Original language | English (US) |
---|---|
Pages (from-to) | 293-302 |
Number of pages | 10 |
Journal | Journal of Law, Medicine and Ethics |
Volume | 49 |
Issue number | 2 |
DOIs | |
State | Published - 2021 |
All Science Journal Classification (ASJC) codes
- General Medicine